Literature DB >> 6499704

Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.

R J Solomon.   

Abstract

Alterations in serum electrolytes may frequently accompany ischaemic heart disease. Many of these patients are hypertensive and receive diuretic therapy which results in chronic lowering of serum potassium and magnesium. In addition, acute catecholamine-induced shifts of potassium into cells may also occur in the setting of acute myocardial ischaemia. An association between low serum potassium concentrations and ventricular arrhythmias has been observed by a number of investigators in patients with acute myocardial infarction. The increased frequency of ventricular fibrillation with low serum potassium concentrations is particularly relevant as this arrhythmia is associated with poor prognosis, even in the setting of a coronary care unit. Ventricular fibrillation also occurs with increased frequency in patients with angina who have low serum potassium levels. The possibility that low serum potassium concentrations may be a risk factor in the increased incidence of sudden death in such patients should be considered. Diuretic-induced magnesium deficiency may be yet another factor favouring the emergence of ventricular arrhythmias in patients with ischaemic heart disease. While such electrolyte disturbances do not account for all of the ventricular irritability seen in patients with ischaemic heart disease, they represent easily identifiable and treatable risk factors. Primary prevention of these electrolyte disturbances in patients at risk for coronary ischaemia is recommended.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499704     DOI: 10.2165/00003495-198400281-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  46 in total

1.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

2.  "Polarizing" solutions in patients with acute myocardial infarction. A double-blind study with negative results.

Authors:  G F Fletcher; J W Hurst; R C Schlant
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

3.  Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment.

Authors:  T Dyckner; P O Wester
Journal:  Am Heart J       Date:  1979-01       Impact factor: 4.749

4.  Mechanism of free fatty acid-induced arrhythmias.

Authors:  S Sugiyama; Y Miyazaki; K Kotaka; T Kato; S Suzuki; T Ozawa
Journal:  J Electrocardiol       Date:  1982       Impact factor: 1.438

Review 5.  Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.

Authors:  C E Rackley; R O Russell; W J Rogers; J A Mantle; H G McDaniel; S E Papapietro
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

6.  Effect of magnesium chloride on electrical stability of the heart.

Authors:  M F Ghani; M Rabah
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

7.  Neural and psychologic mechanisms and the problem of sudden cardiac death.

Authors:  B Lown; R L Verrier; S H Rabinowitz
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

8.  The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

Authors:  A D Struthers; J L Reid; R Whitesmith; J C Rodger
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

9.  Importance of potassium in patients with acute myocardial infarction.

Authors:  R J Solomon; A G Cole
Journal:  Acta Med Scand Suppl       Date:  1981

Review 10.  The heart cell: some metabolic aspects of cardiac arrhythmias.

Authors:  W G Nayler
Journal:  Acta Med Scand Suppl       Date:  1981
View more
  8 in total

1.  Effect of beer consumption on plasma magnesium: randomized comparison with mineral water.

Authors:  S Gorinstein; M Zemser; I Libman; S Trakhtenberg; A Caspi
Journal:  J R Soc Med       Date:  1998-12       Impact factor: 5.344

2.  Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.

Authors:  M J Paletta; S Abraham; G N Beatch; M J Walker
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

3.  The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat.

Authors:  M J Curtis; B A Macleod; M J Walker
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

4.  Effects of magnesium on ischemic and reperfusion arrhythmias in the rat heart and electrophysiologic effects of hypermagnesemia in the anesthetized dog.

Authors:  A Keren; P Dorian; J M Davy; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

Review 5.  Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.

Authors:  I Rajman; M J Kendall
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401

6.  High-Normal Serum Magnesium and Hypermagnesemia Are Associated With Increased 30-Day In-Hospital Mortality: A Retrospective Cohort Study.

Authors:  Liao Tan; Qian Xu; Chan Li; Jie Liu; Ruizheng Shi
Journal:  Front Cardiovasc Med       Date:  2021-02-10

Review 7.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19

Review 8.  The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers.

Authors:  Ferdinando Barretta; Bruno Mirra; Emanuele Monda; Martina Caiazza; Barbara Lombardo; Nadia Tinto; Olga Scudiero; Giulia Frisso; Cristina Mazzaccara
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.